Preoperative consumption of N-Acetyl Cysteine and melatonin during CABGS
Not Applicable
- Conditions
- I20-I25Diseases of the circulatory system.Ischaemic heart diseases
- Registration Number
- IRCT201304178129N3
- Lead Sponsor
- Deputy of Research,Bushehr University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
The inclusion criteria:
1-Not having weak left ventricular function.
2- Non diabetics.
3- Non emergency patients.
4- patients without history of endocrine, pulmonary, metabolic and neurological diseases.
Exclusion criteria:
1- Emergency patients.
2-Diabetic patients.
3- patients having history of endocrine, pulmonary, metabolic and neurological diseases.
4- smokers.
5-patients having weak left ventricular function.
6-Patients consuming melatonin and N-Acetyl cysteine at least from two weeks before the operation.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method